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ABSTRACT
Damages in the DNA template inhibit the pro-
gression of replication, which may cause single-
stranded gaps. Such situations can be tolerated by
translesion DNA synthesis (TLS), or by homology-
dependent repair (HDR), which is based on transfer
or copying of the missing information from the
replicated sister chromatid. Whereas it is well
established that TLS plays an important role in
DNA damage tolerance in mammalian cells, it is
unknown whether HDR operates in this process.
Using a newly developed plasmid-based assay that
distinguishes between the three mechanisms of
DNA damage tolerance, we found that mammalian
cells can efficiently utilize HDR to repair DNA gaps
opposite an abasic site or benzo[a]pyrene adduct.
The majority of these events occurred by a physical
strand transfer (homologous recombination repair;
HRR), rather than a template switch mechanism.
Furthermore, cells deficient in either the human
RAD51 recombination protein or NBS1, but not
Rad18, exhibited decreased gap repair through
HDR, indicating a role for these proteins in DNA
damage tolerance. To our knowledge, this is the
first direct evidence of gap-lesion repair via HDR in
mammalian cells, providing further molecular
insight into the potential activity of HDR in
overcoming replication obstacles and maintaining
genome stability.
INTRODUCTION
During DNA replication, damaged template nucleotides
hinder the progression of the replication machinery.
Stalled replication forks may either be resolved directly,
by the recruitment of specialized proteins, or replication
could be re-initialized further-on resulting in the forma-
tion of a single stranded gap. In this context, damaged
nucleotides cannot be repaired through excision, and
continuing replication necessitates the enlistment of
DNA damage tolerance mechanisms, which restore the
double stranded structure of the DNA (1–4).
The tolerance of DNA damage may occur in one of two
possible mechanisms. These are translesion DNA synthe-
sis (TLS) and homology-dependent repair (HDR) [We use
the term HDR for all repair mechanisms that rely on
a homologous donor; this includes strand transfer from
the donor (commonly termed homologous recombination
repair, HRR), and template switch mechanisms, in which
the information is copied from the donor] (1). In TLS,
specialized DNA polymerases insert a nucleotide across
from the damage. However, the miscoding nature of
damaged templates renders such a process inherently
error prone (5–7). In HDR, the missing information is
transferred from a homologous molecule, be it the hom-
ologous chromosome or the sister chromatid. While in
bacteria and yeast, homologous recombination (HR) in
general appears to be prevalent, the situation in somatic
mammalian cells is less clear. Despite reports on low
eﬃciencies of homology-directed sequence integration
into the genome (8–10) and spontaneous recombination
events (11–14), actual recombination eﬃciencies are diﬃ-
cult to measure, and may in fact be higher than it appears
from those studies. The underlying logic for low HR
in mammalian cells relies on the possible deleterious
consequences of illegitimate HR events. For instance, a
recombination event between repetitive sequences on dif-
ferent chromosomes could cause gross chromosomal
aberrations. However, this does not exclude the possibility
of highly eﬃcient HR mechanisms under certain
conditions.
HDR has been established to play a role in DNA
double-strand break (DSB) repair in mammalian cells
(15–18). This role appears to be minor compared to the
alternative repair mechanism, non-homologous end
joining (NHEJ) (19–23). However, HDR is also induced
by agents that neither form DSB nor induce NHEJ. These
include alkylating agents, heavy metals, agents that form
bulky adducts (e.g. benzo[a]pyrene; BP), cross linkers and
UV light (17,24–26). This implies that a HDR may be
utilized for the repair of DNA lesions other then DSB.
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indeed substrates for HDR; however, this was assayed in
the absence of a chemical DNA damage (17,26–28).
While in Escherichia coli and Saccharomyces cerevisiae
the operation of HDR is well established (1), and
estimated to be responsible for most DNA damage toler-
ance events (29–32), the existence of such a process in
mammalian cells has not been yet proven. A mechanism
utilizing HR for gap-lesion ﬁlling is certainly feasible in
mammalian cells as all the necessary machinery is present.
Homologs and paralogs of most yeast recombination
proteins exist in mammalian cells (33,34). Furthermore,
an activity of HDR is expected to be needed either
during or immediately after replication, when a sister
chromatid is in cohesion, thus minimizing the risk for
an illegitimate event. In addition, in contrast to the
alternative TLS mechanism, it does not bear an inherent
mechanistic mutagenic property (although under certain
conditions it can cause gross DNA changes such as
rearrangements and deletions).
In this study, we set out to establish whether HDR can
play a role in DNA damage tolerance in mammalian cells.
In order to do so, we utilized a plasmid-based assay system
as a model for post-replicative gap repair. We show that
mammalian cells can eﬃciently utilize HDR to ﬁll in gaps
opposite lesions. The process occurs primarily via a strand
transfer rather than template switch mechanism, and
involves RAD51 and NBS1 but not Rad18.
MATERIALS AND METHODS
Cell culture
The human large cell lung cancer cell line H1299 (35) was
grown in RPMI 1640 medium supplemented with 10%
fetal bovine serum, 2mM glutamine, 100U/ml penicillin
and 100mg/ml streptomycin. The human colon cancer
cell line HCT116 (36,37) was cultured in McCoy’s 5A
medium supplemented with 10% fetal bovine serum,
2mM glutamine, 100U/ml penicillin and 100mg/ml
streptomycin. The SV40 transformed NBS1 ﬁbroblasts
and their complemented controls (37) and the Rad18
+/+
and Rad18
 /  MEF (38) were grown in DMEM media
supplemented with 10% fetal bovine serum, 2mM gluta-
mine, 100U/ml penicillin and 100mg/ml streptomycin.
Construction of DNA substrates
The gapped plasmids (GPs) were synthesized as previously
described (39,40). Homologous linear DNA donors were
synthesized by restriction of closed circular plasmids
identical in sequence to ﬁlled GPs (pFGP) bearing either
cm
R or amp
R instead of the kan
R genes. The homologous
donor DNA (hDNA) is the 1072 restriction product of the
digestion of either plasmid with the DraI and HindIII
enzymes. The homologous plasmids used as donors for
GP-abasic (pFGP-C-amp and pFGP-T-amp) were amp
R
kan
S derivatives of previous TLS experiments. The con-
struction of these plasmids was conducted by digestion of
pFGP21-C/T with XhoI and HindIII, deleting a 520-bp
fragment from the Kan gene, and ligating the restricted
plasmids to a 945-bp fragment carrying PCR termini with
XhoI and HindIII sites, and the bla gene from plasmid
pUC18 conferring amp
R. The additional hDNA molecules
were obtained from closed circular pFGP plasmids bearing
cm
R (pFGP-cm). In order to obtain these plasmids, cm
R
vector DNA (the BstXI–BsaI restriction product of
pSKSL-cm) was ligated to an appropriate double-stranded
insert DNA (achieved by annealing of two oligo-
nucleiotides) in order to achieve the sequence homologous
to the speciﬁc GP but with the additional recombination
markers. For hDNA-BPG, the two oligonucleotides were:
50-ACCGCAACGAAGTGATTCGGCATCCGTCCTA
CTGGCTACTTGAACCAGACCG-30, and 50-TGGTTC
AAGTAGCCAGTAGGACGGATGCCGAATCACTT
CGTTG-30. After ligation, DNA was transformed into
competent cells, plasmid DNA was isolated from speciﬁc
colonies and its sequence veriﬁed. For the construction of
the mismatch bearing homologous donors, the oligo-
nucleotides were designed to bear the speciﬁc mismatch.
These were: 50-CTGGTTCAAGTAGCCCAGGTTTTCT
CAGTCACGACGGGAATACACTTCGTTG-30 and
50-ACCGCAACGAAGTGATTCCCGTGACTGGGAA
AACCTGGGCTACTTGAACCAGACCG-30 for the
G:T mismatch; 50-CTGGTTCAAGTAGCCCAGGTTT
TCCCAGTCACGACGGGAATACACTTCGTTG-30
and 50-ACCGCAACGAAGTGATTCCCGTGACTGAG
AAAACCTGGGCTACTTGAACCAGACCG-30 for the
A:C mismatch; 50-CTGGTTCAAGTAGCCCAGG-TTT
TCCCAGTCACGACGGGAATACACTTCGTTG-30
and 50-ACCGCAACGAAGTGATTCCCGTGACTGCG
AAAACCTGGGCTACTTGAACCAGACCG-30 for the
C:C mismatch; and 50-CTGGTTCAAGTAGCCCAG
GTTTTCGCAGTCACGACGGGAATACACTTCGTT
G-30 and 50-ACCGCAACGAAGTGATTCCCGTGACT
GGGAAAACCTGGGCTACTTGAACCAGACCG-30
for the G:G mismatch. After ligation to the cm
R vector
(150mg), the closed circular plasmid was run on 0.8% agar-
ose gel and the required fragment was eluted using the
Elutrap electro-elution extraction protocol. This plasmid
(10mg) was then restricted with HindIII and DraI and the
restrictionproductswereoncemoreseparatedon0.8%gels
and the 1072-bp segment was extracted by elutrap. The
non-homologous DNA donor (nhDNA) was the 1012
SspI and HindIII restriction fragment of pCDNA3,
which shares no homology with the GP.
Gapped plasmif repair assay
The in vivo assay for repair of GP by TLS and HDR
is similar to the TLS assay previously described (40–42).
It involves the transient transfection of the cells using the
jetPEI transfection reagent (polyplus transfection, Illkirch,
France) with a DNA mixture containing 50ng of the gap-
lesion plasmid (kan
R), 50ng of a normalizing GP without
a lesion (cm
R) and 5–10mg of pUC18, as carrier plasmid.
When assaying for HRR, 150ng of hDNA was also
introduced into the DNA mixture. Following an incuba-
tion period suﬃcient for gap ﬁlling (4–8h), plasmids were
extracted from the cells. Plasmid gap ﬁlling repair was
assayed by introduction of the recovered DNA mixture
into an E. coli recA strain, followed by plating on LB-
kan and LB-cm to select for ﬁlled-in gap-lesion and
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calculated by dividing the number of kan
R colonies by
the number of cm
R colonies. The necessity for the use
of a normalizing GP is due to the fact that the actual
number of transformant colonies obtained in the diﬀerent
experiments varies depending on the cell line and the
gap plasmid used, the gap ﬁlling eﬃciency, and the trans-
formation eﬃciencies. Therefore, diﬀerent fractions of
the extracted DNA mixtures were taken to transform
the indicator E. coli strain, and diﬀerent volumes of
transformed bacteria were plated. In order to present the
data in simpliﬁed form, which allows comparison between
experiment sets, the number of colonies was adjusted to a
common volume of transformation mixture (100ml).
Extraction of the plasmids from the cells is conducted
by alkaline conditions followed by renaturation, which
allow for the recovery only of covalently closed, and
thus completely ﬁlled in GPs. In this way, we assure that
only the ﬁlled-in GPs recovered were indeed introduced
into the bacteria cells.
To determine the DNA sequence changes that have
occurred during plasmids repair, sequence analysis was
carried using the TempliPhi DNA Sequencing Template
Ampliﬁcation Kit (GE Healthcare) and the BigDye
Terminator v1.1 Cycle Sequencing Kit (Applied Bio-
systems). Reactions were analyzed by capillary electro-
phoresis on a 3130xl Genetic Analyzer (Applied
Biosystems). The repair by HRR or TLS was calculated
by multiplying total plasmid repair levels by the fraction
of HRR or TLS events out of the total sequences
analyzed.
Knocking-down the expression of RAD51
Knocking-down of RAD51 expression was conducted by
transfection of SmartPool siRNA (10nM, using
Dharmafect 2, Dharmacon) to H1299 cells. Analysis of
knock down was conducted by western blot with PC130
polyclonal anti-RAD51 antibody (Chalbiochem, 1:2500),
compared to tubulin levels (mouse polyclonal antibody,
Sigma, 1:15000). In gap-repair experiments, the cells
were transfected with siRNA, 72h after initial trans-
fection, cells were re-transfected and the experiment was
conducted 72h after the second siRNA boost.
RESULTS
HDR can efficiently fill in gap-lesion structures
in mammalian cells
To examine whether mammalian cells can ﬁll in DNA
gaps opposite lesions, we made use of a model shuttle
assay, based on a plasmid carrying a gap opposite a site-
speciﬁc DNA damage (modeling a post-replication gap),
and a homologous linear dsDNA (modeling a sister
chromatid) (Figure 1A). The two DNAs were used to
transfect cultured human cells, in which gap ﬁlling could
in theory occur by TLS, or by HDR using the homologous
DNA as a donor. Analysis was done by extracting the
plasmid content from the mammalian cells under alkaline
conditions followed by renaturation, allowing only
completely repaired, covalently closed plasmids to
remain intact, and using it to transform an indicator
E. coli recA strain to kanamycin-resistance (the marker
present on the plasmid). Plasmids were then isolated
from individual colonies and subjected to DNA sequence
analysis. Including in the transfection a GP without
a lesion (and carrying a chloramphenicol-resistance
gene) enabled determination of the eﬃciency of gap-
lesion plasmid repair by calculating the ratio of kan
R to
cm
R E. coli colonies. A similar assay (without the donor)
has previously been useful in studying TLS in mammalian
cells (39–44).
The lesion opposite the gap was a synthetic abasic site,
representing one of the most common lesions in DNA.
The donor homologous DNA carried a T opposite the
location corresponding to the abasic site (because T is
rarely inserted opposite this lesion), and two nearby
markers: a  1 deletion and a single base substitution
(hDNA-T; Figure 1B). This enables discrimination
between gap ﬁlling by HDR (T opposite the abasic site
and the nearby markers) and TLS (insertion of nucleotides
or  1 deletions and no nearby markers) (Figure 1B).
Table 1 and Figure 2A describe the results of an experi-
ment in which human H1299 cells were transfected with a
mixture of a GP carrying an abasic site (kan
R), the donor
linear dsDNA, and the normalizing GP (cm
R). Plasmid
repair in the presence of the homologous donor (37%)
was 3.5-fold higher than with a heterologous donor
(10.7%). Consistently, 84% of the former contained the
HDR markers, as opposed to none (0/54) of the latter
(Table 2 and Figure 2B). Importantly, only 5% of the
isolates contained large deletions, indicative of breakage
of the gap-lesion plasmid, followed by NHEJ (Table 2,
‘Other events’). This indicates that when present in the
mammalian cells, most of the gap-lesion substrates were
not linearized by nicking at the ssDNA region. The gap
ﬁlling HDR reaction was observed also with a GP
carrying a site-speciﬁc bulky benzo[a]pyrene-guanine
adduct (BP-G), (Tables 1 and 2 and Figure 2A and B).
Interestingly, the presence of a lesion opposite the gap was
required, since when the GP without a lesion was
analyzed, only 2% of the isolates (1/42) carried the
HRR markers (Table 2 and Figure 2B). Control
experiments, in which the DNA mixture (non-denatured)
was introduced directly into the E. coli indicator-strain
veriﬁed that the HDR events did not occur in the indicator
E. coli (Table 3). When the DNA mixture was denatured
prior to E. coli transformation, extremely low transform-
ation eﬃciency was observed, as expected from a recA
strain (39).
HDR is mediated primarily by physical transfer of the
homologous DNA strand
The homologous recombination event could theoretically
occur by one of two mechanisms. The complementary
strand could be ﬁlled-in by direct transfer from the
homologous donor, in a ‘cut and paste’ mechanism
(strand transfer recombination). On the other hand, the
homologous donor could serve as an alternative template
for DNA synthesis, instead of the damaged template in the
gap, (template switch; Figure 3A). In order to distinguish
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we constructed homologous donor molecules bearing a
mismatch at the position corresponding to the lesion in
the GP (Figure 1B). The two donors initially used had
either a G:T or an A:C mismatch (hDNA-G:T and
hDNA-A:C, respectively). With the G:T mismatch, a
strand transfer event, in which physical transfer occurs,
would result in the occurrence of a T across from the
lesion in the recovered plasmid. A template switch event,
however, would involve the use of the homologue as an
alternative template, insertion of a C across from the G,
and a C in the product (Figure 3A). In experiments with
the reciprocal A:C mismatch, a C indicates strand trans-
fer and a T indicates a template switch event, thus ruling
out a bias for either a C or a T as a product (Figure 3A).
This assay system requires that the mismatch remain
unrepaired throughout the experiment. In order to ascer-
tain this, we conducted control experiments in which a
control closed circular DNA bearing the mismatch and a
cm
R marker was used to transiently transfect the cells,
Figure 1. A plasmid-based assay for the repair of gaps opposite lesions. (A) Outline of the experimental system. See text for details. (B) Relevant
sequences of the GPs and the homologous donors used in this work. X represents the synthetic abasic site, and the star underneath the G—the
benzo[a]pyrene-guanine adduct. hDNA, homologous DNA. The site of the lesion and the appropriate recombination markers are indicated by long
and short vertical rectangles, respectively.
Table 1. Enhanced ﬁlling in of gaps opposite lesions in the presence of
homologous DNA
Lesion opposite
the gap in the
plasmid
Donor
DNA
E. coli transformants
a Plasmid
repair
b (%)
Kan
R Cm
R
Abasic site None 104 679 12.1 3.7
nhDNA 25 340 10.7 2.6
hDNA 94 200 37 7.9
BP-G None 47 648 5.4 1.2
hDNA 89 258 15.9 5.1
H1299 cells were transfected with a DNA mixture containing the
indicated gap-lesion plasmid (kan
R) and the control gap-plasmid (cm
R)
in the presence or absence of a linear donor (homologous, hDNA, or non-
homologous, nhDNA). Following 8h incubation, the DNA was extracted
and used to transform an E. coli indicator strain. Plasmid repair was
calculated based on the ratio of kan
R/cm
R colonies.
aThe number of transformants obtained in a typical assay with 100mlo f
transformation mixture.
bPlasmid repair values are the averages of six experiments, and
therefore are not exactly equal to the ratios of Kan
R to Cm
R colonies
presented in the two previous columns, which show the results of
a single typical experiment.
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match repair-deﬁcient E. coli mutS strain. The underlying
logic was that unrepaired, mismatch-bearing plasmids
would yield a bacterial colony containing a mixed popu-
lation of plasmids (with both a C and a T at the speciﬁc
position). Sequencing of plasmids obtained from such
colonies would result in both a C and a T at this position
(an N in the sequence output), as was indeed found to be
the case (data not shown).
When the assay was conducted with hDNA-G:T
(Table 4 and Figure 3B) in H1299 cells, 24/35 sequences
carried the HDR markers, of which 83% had a T,
indicating a strand transfer mechanism (Table 4 and
Figure 3B). Similarly, with the reciprocal hDNA-A:C,
strand transfer constituted 85% of the recombination
events. A similar preference for strand transfer was
obtained with the human cell line HCT116, which is mis-
match repair-deﬁcient (Table 4 and Figure 3B).
Since G:T mismatches can be repaired by a mechanism
independent of the general mismatch repair system (1), and
as an additional mean to rule out mismatch repair bias, we
repeated similar experiments in H1299 cells with the hom-
ologous donors hDNA-C:C and hDNA-G:G, carrying a
C:C or a G:G mismatch, respectively, at the position
corresponding to the lesion in the GP (Figure 1B). With
the C:C mismatch strand transfer is expected to yield a C
opposite the location corresponding to the lesion, whereas
template switch—a G. With the G:G mismatch strand
transfer is expected to yield a G opposite the location
corresponding to the lesion, and template switch—a C.
As can be seen in Table 4 and Figure 3B, with the C:C
mismatch 31/35 of the gap repair events carried the HDR
markers, and 77% (24/31) of those had a C opposite the
location corresponding to the lesion, indicating strand
transfer HDR. With the G:G mismatch 41/48 events
A
B
Figure 2. HDR repairs gaps opposite lesions in human cells.
(A) Homology-dependent repair enhances repair of gaps opposite an
abasic site or a BP-G adduct in the human H1299 lung cancer cell line.
See Table 1 for details. (B) The percentage of repair events by HDR from
the experiments depicted in (A), and presented in detail in Table 2.
Table 2. DNA sequence analysis of gap ﬁlling opposite site-speciﬁc
lesions in the presence of a homologous donor
Gapped plasmid (GP) GP-abasic GP-abasic GP-BP-G Control GP
Donor DNA nhDNA hDNA hDNA hDNA
Nucleotide inserted
opposite the lesion,
or event type
A1 0 1 1 –
C1 7 3 3 –
G ––– –
T1 – – –
( 1) 22 5 – –
( 2) 1 – – –
HDR product 0 (<2%) 48 (84%) 28 (82%) 1 (2%)
Control GP sequence – – – 41
Other events 3 – 2 –
Total number
of isolates
54 57 34 42
H1299 cells were transfected with a DNA mixtures containing a plas-
mid with a gap opposite a synthetic abasic site (GP-abasic; kan
R)o ra
BP-G adduct (GP-BP-G; kan
R) or the control GP (cm
R) in the pres-
ence of a hDNA or nhDNA, DNA partner. Following 8h incubation,
plasmids were extracted from the cells and used to transform an E. coli
indicator strain. Plasmids were extracted from either kan
R or cm
R
colonies and subjected to sequence analysis. Shown is the DNA se-
quence opposite the lesion obtained from individual colonies. HDR
products are detected based on the nucleotide across from the lesion
as well as the presence of the speciﬁc recombination markers,
transferred from the hDNA sequence (Figure 1B). The single-nucleotide
insertions opposite the lesions are due to TLS. For the GP-abasic and
Control GP plasmids the hDNA used was hDNA-T. For the GP-BP-G
it was hDNA-G. Other events are primarily large deletions.
Table 3. DNA sequence analysis of descendants of gap-lesion plasmids
that were introduced into the E. coli recA indicator strain without prior
passage in mammalian cells
Homologous donor Number of isolates (%)
nhDNA hDNA
Nucleotide inserted opposite
the abasic site
A– –
C– –
G– –
T 1 (8) –
HDR product ––
Deletions ( 1) 11 (92) 24 (100)
Total number of isolates 12 24
DNA mixtures containing the gap-lesion plasmid carrying an abasic
site (kan
R) together with a linear hDNA or nhDNA DNA molecule
were used to directly transform the E. coli recA indicator strain.
Plasmids were extracted from kan
R colonies and subjected to sequence
analysis. Shown is the DNA sequence opposite the lesion obtained
from individual colonies. No HDR products were detected.
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G opposite the location corresponding to the lesion,
indicating strand transfer HDR. Taken together, gap
repair via HDR exhibits a strong preference for a strand
transfer mechanism.
RAD51 and NBS1, but not Rad18, play a role in
gap filling through HRR
The major eukaryotic recombinase is the RAD51 protein,
the homologue of the E. coli RecA (45). In E. coli, RecA
is involved in both TLS and HDR (1). In mammalian
cells, it is an essential gene and cannot be knocked out.
Experiments were conducted in H1299 cells trans-
fected with either siRNA directed against RAD51 or
control siRNA treated cells. Knockdown was veriﬁed
by immunobloting with an anti-RAD51 antibody
(Figure 4A), and gap-lesion repair was analyzed for a
gap opposite an abasic site. Treatment of the cells with
siRAD51 aﬀected viability only after the second siRNA
transfection boost. This was observed in reduced plating
eﬃciencies (about four times less cells). The experiments
were conducted under the same conﬂuence in siRAD51
and siControl treated cells. The use of a normalizing plas-
mid controls for all the factors but those involved in
tolerating the damage. As can be seen in Table 5 and
Figure 4B, HDR was reduced by 2.3-fold compared to
cells treated with control siRNA. A similar eﬀect was
observed on TLS.
In order to establish whether the NBS1 gene product
played a role in gap-ﬁlling recombination, we conducted
similar experiments with the abasic site bearing plasmid in
SV40 transformed NBS1 ﬁbroblasts and their comple-
mented controls. Our results show a 2.6-fold decrease in
the repair of gap-lesion plasmids by HDR in NBS1 deﬁ-
cient cells, while TLS was unaﬀected (Table 6 and
Figure 4C). In contrast, experiments performed in
Rad18 knockout MEFs compared to wild type controls
showed that the Rad18 gene did not aﬀect gap-ﬁlling
HDR, while it was required for TLS (Table 7 and
Figure 4D).
A
B
Figure 3. Gap-ﬁlling by HDR occurs predominantly by a strand transfer mechanism. (A) A scheme illustrating strand transfer and template switch
homology-dependent repair (HDR; HRR) mechanisms for ﬁlling in gaps opposite a lesion (indicated by a star). See text for details. (B) Fraction of
HDR events occurring via strand transfer (black columns) and template switch (gray columns). Shown are results in HCT116 (mismatch repair
defective) and H1299 human cell lines, with a donor carrying either a G:T, A:C, C:C or G:G mismatch. Detailed data are presented in Table 4.
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CD
B
Figure 4. Involvement of RAD51 and NBS1, but not Rad18, in gap-ﬁlling HDR. (A) Immunoblot analysis showing siRNA knock-down of RAD51
expression in H1299 cells either without (lanes 1 and 3) or with (lanes 2 and 4) transfection with the gapped DNAs. See methods for details.
(B) Results of experiments in H1299 cells in which RAD51 was knocked-down show more then a 2-fold reduction in both HDR and TLS.
(C) Experiments conducted in NBS1 cells show signiﬁcant reduction in HDR without aﬀecting TLS. (D) Experiments conducted in Rad18
 / 
MEFs show strong decrease in TLS in the RAD18 deﬁcient cells with no eﬀect on HDR. See Tables 5–7 for details.
Table 4. The majority of HDR events occur through a strand transfer mechanism
Number of isolates
Mismatch in donor G:T A:C C:C G:G
Cell line H1299 HCT116 H1299 HCT116 H1299 H1299
Event type
Base substitutions
A4 1 2 – 2 4
C3 – 3 – – –
G– – 1 – – –
T– – 1 – – –
( 1 ) 35 91 12
( 2 ) –– –– 11
T HDR 20 36 10 16 – –
C HDR 46 34 29 24 4
G HDR –– –– 7 37
Large deletions 1 – – – 2 2
Total number
of isolates
35 48 60 46 37 50
DNA mixtures containing the gap plasmid carrying the abasic site (kan
R) together with a homologous donor bearing either a G:T, an A:C, a C:C
or a G:G mismatch at the lesion position were used to transfect the human cell lines H1299 or HCT116. Following 8h incubation, DNA was
extracted and used to transform an indicator E. coli strain. Plasmids were extracted from kan
R colonies and subjected to sequence analysis. HDR
products were identiﬁed based on the base at the position across from the lesion: a C or a T for the G:T and A:C mismatches, and a C or a G for
the C:C and G:G mismatches, as well as the additional ( 1) deletion recombination marker (Figure 1B). In the presence of a G:T mismatch, the
product of a strand transfer mechanism is a T at the position across from the lesion, whereas a template switch mechanism would result in a
C. In the presence of an A:C mismatch, a C indicates strand transfer whereas a T indicates template switch. With a C:C mismatch a C indicates
strand transfer and a G indicates a template switch, whereas with the G:G mismatch a G indicates strand transfer whereas a C indicates template
switch. The HDR strand transfer events are in bold type.
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There is accumulating evidence that ssDNA gaps are
formed in a variety of cells following treatment with
DNA-damaging agents, including E. coli, S. cerevisiae
and human cells (2–4,46). These gaps can be ﬁlled by
either TLS or HDR. Based on the S. cerevisiae paradigm
(47), two HDR pathways have been proposed, which
diﬀer by the mode by which the homologous donor
(usually a sister chromatid) is used to ﬁll in the gap
opposite the lesion. In strand transfer HDR the gap is
ﬁlled by physical transfer of the complementary strand
from the donor, whereas in template-switch HDR the
missing segment is copied from the donor. Gap ﬁlling tol-
erance by HDR—be it via strand transfer or template
switch mechanisms—oﬀers a potential advantage over
TLS in being inherently accurate, in contrast to the inher-
ently error-prone nature of TLS. Yet, while the operation
of TLS is well established in mammalian cells, the oper-
ation of the two HDR mechanisms in ﬁlling in gaps
opposite lesions has been more diﬃcult to pin down.
The use of the plasmid-based shuttle assay system,
which contains a deﬁned model HDR substrate, enabled
us to establish, for the ﬁrst time, that gaps opposite lesions
can be accurately ﬁlled in by HDR in mammalian cells in
general, and human cells in particular. Our data indicate
that in this system the events detected in the E. coli indi-
cator strain have occurred in the mammalian cells, and
not in the indicator bacterial cells. This conclusion is
supported by the following arguments: (i) the E. coli
strain used was RecA-deﬁcient and therefore defective in
both HRR and TLS across abasic sites and BP-G adducts
(1). (ii) The extraction of the plasmid from the mammalian
cells was done using a protocol of alkaline denaturation
followed by renaturation. Under such conditions all
gapped or nicked plasmids remain denatured, and
poorly transform the indicator E. coli strain. Only plas-
mids that have been fully ﬁlled in and ligated in the mam-
malian cells remain covalently closed and were able to
transform the indicator E. coli cells. (iii) Transformation
of the E. coli cells without prior passage in the mamma-
lian cells yielded a background and extremely low number
of colonies. (iv) DNA sequence of plasmids from
transformants that were obtained from E. coli cells with-
out prior passage through mammalian cells did not show
any of the markers of HDR.
Our conclusion that the gap ﬁlling events that we have
observed in the mammalian cells represent HDR are
supported by their dependence on a homologous donor,
on the dependence on a DNA lesion opposite the gap in
the acceptor, on the presence of the donor markers in the
Table 5. RAD51 is involved in gap-lesion repair by both TLS and HDR in human cells
Treatment DNA substrate mix E. coli transformants
a Plasmid repair (%) TLS
b (%) HDR
b (%)
Kan
R Cm
R
siRAD51 GP-abasic+hDNA 129 751 13.1 5.1 6 2.3 6.2 2.4
siControl GP-abasic+hDNA 187 460 29.6 5.8 14.5 2.8 14.5 2.8
Number of isolates (%)
Treatment siRAD51 siControl
Plasmid type GP-abasic+hDNA GP-abasic+hDNA
Event type
Base substitutions
A7 1 8
C5 5
G1 2
T– –
( 1) deletion 17 4
( 2) deletion – –
Complex TLS events
c 4
Total TLS 30 (46%) 33 (49%)
HDR product 31 (47%) 33 (49%)
Other events
d 52
Total number of isolates 66 68
H1299 cells were transfected with siRNA directed against RAD51 or control siRNA. Once knock down was established, the DNA mixture containing
the gap plasmid bearing an abasic site (kan
R) and the control gap-plasmid (cm
R) in the presence of hDNA was introduced into the cells. Following
8h incubation, the DNA was extracted and used to transform an E. coli indicator strain. Plasmid repair was calculated based on the ratio of kan
R/
cm
R colonies. Each result represents the average of at least four experiments. Results of single gap-ﬁlling events were obtained by sequence analysis
of plasmid DNA extracted from single kan
R colonies. Depicted is the sequence at the position across from the lesion.
aThe number of transformants obtained in a typical assay with 100ml of transformation mixture.
bThe repair by HDR or TLS was calculated by multiplying total plasmid repair levels by the fraction of HDR or TLS events out of the total
sequences analyzed.
cComplex TLS events involved mutation in the adjacent nucleotides. These were ACC, CAG, CCT and CCCC instead of CXC, when X represents
the position across from the damage.
dOther events depict several base pair deletions or insertion of non-homologous sequence.
5744 Nucleic Acids Research, 2009, Vol. 37,No. 17descendents of the ﬁlled in gap-lesion plasmids, and by the
eﬀects on gap-ﬁlling in cells deﬁcient in genes related to
TLS and HDR.
Based on the S. cerevisiae paradigm the Rad18 ubiqui-
tin ligase controls both TLS and template-switch HDR,
but not strand transfer HDR, whereas the Rad51 recom-
bination protein is involved both modes of HDR (1,47).
Consistently, gap ﬁlling by HDR in our assay was
decreased in a human cell line in which the expression of
RAD51 was knocked-down, but not in a Rad18
 /  MEF,
compared to their ‘wild-type’ counterparts. Of note are the
contrasting eﬀects observed in NBS1
 /  and Rad18
 / 
mutant cells: whereas the former aﬀected HDR but not
TLS, the latter aﬀected TLS but not HDR. The function
of the NBS1 protein is not fully understood, but its
involvement in gap ﬁlling HDR is consistent with the
ﬁnding that XRS2, the yeast homologue of NBS1,i s
involved in the two HDR pathways (47).
RAD51 is the eukaryotic homologue of the E. coli recA,
which is known to be involved in bacterial DNA damage
tolerance through both TLS and HRR (1). In mammalian
cell, however, RAD51 is an essential gene and cannot be
knocked out (48,49). We therefore resorted to knocking
down the expression of RAD51 using siRNA. Under con-
ditions where RAD51 expression was eﬀectively knocked-
down ( 95%), gap ﬁlling was reduced by 2.3-fold
compared to cells treated with a control siRNA. This
rather moderate eﬀect might be an underestimation of the
RAD51 dependence in chromosomal gap ﬁlling by HDR,
and may stem from the use of the plasmid model assay
system, and gaps much shorter than chromosomal gaps.
Under these conditions, either residual RAD51 activity,
or the activity of homologous proteins with redundant
function, may be responsible for partially promoting
HDR. Nevertheless, these results suggest that RAD51 is
involved in the gap-ﬁlling reaction through both HDR
and TLS. A role of RAD51 in mammalian TLS was not
previously reported, and warrants further investigation,
however,itisnoteworthythathumanRAD51wasreported
to interact with DNA polymerase Z, one of the major TLS
polymerases (50). This resembles the situation in E. coli,
whereRecAisrequiredforboth TLSandHDR, suggesting
functional evolutionary conservation.
The design of a donor DNA with a mismatch at the
location corresponding to the damaged site in the acceptor
plasmid enabled us to assay simultaneously strand transfer
and template switch mechanisms of HDR. Our results in-
dicate that the majority of gap ﬁlling events had occurred
via a strand transfer mechanism. We take these results to
indicate that there are situations in the cell under which
strand transfer predominates over template switch as the
HDR gap repair mechanism, e.g. the ﬁlling in of post-
replication gaps. This is similar to the results obtained
with a plasmid system in E. coli (29,30) and with the
Table 6. NBS1 is involved in gap-lesion repair by HDR but not TLS in human cells
Cell line E. coli transformants
a Plasmid repair (%) TLS
b (%) HDR
b (%)
Kan
R Cm
R
Transformed NBS1
 /  182 635 34.6 10.1 12.5 3.6 13.1 3.6
Transformed Comp. 109 185 49.7 7.5 11.9 3.8 34.2 10.9
Number of isolates (%)
Cell line NBS1
 /  NBS1-complemented
Plasmid type GP-abasic+hDNA GP-abasic+hDNA
Event type
Base substitutions
A1 0 7
C2 1
G– –
T3 2
HDR product 18 (38%) 37 (69%)
Deletions – –
( 1) 2 3
Other events
c 12 4
Total number of isolates 47 54
Transformed GM07166 NBS1 cells and their complemented controls were transfected with DNA mixture containing the gap plasmid bearing an
abasic site (kan
R) and the control gap-plasmid (cm
R) in the presence of homologous DNA (hDNA). Following 4h incubation, the DNA was
extracted and used to transform an E. coli indicator strain. Plasmid repair was calculated based on the ratio of kan
R/cm
R colonies. Each result
represents the average of four experiments. Results of single gap-ﬁlling events were obtained by sequence analysis of plasmid DNA extracted from
single kan
R colonies. Depicted is the sequence at the position across from the lesion.
aThe number of transformants obtained in a typical assay with 100ml of transformation mixture.
bThe repair by HDR or TLS was calculated by multiplying total plasmid repair levels by the fraction of HDR or TLS events out of the total
sequences analyzed.
cOther events depict several base pair deletions or insertion of non-homologous sequences.
Nucleic Acids Research, 2009,Vol.37, No. 17 5745Howard–Flanders model for HRR in UV irradiated
E. coli cells (46,51). However, there might exist situations
in which template switch will be preferred. For example,
when replication forks encounter DNA lesions tem-
plate switch may be favored over strand transfer as a
damage tolerance mechanism (52). In addition, there
might be a discrimination between the leading and
lagging strands, with template switch favored on the
former, and strand transfer on the latter, as suggested
for S. cerevisiae (47).
In summary, our results indicate, for the ﬁrst time,
that mammalian cells can repair gaps opposite lesions
by HDR, acting primarily by a strand transfer
mechanism. This mechanism involves RAD51 and
NBS1, but not Rad18. Additional studies assaying directly
chromosomal HDR are needed to examine whether
such mechanisms operate in the context of mammalian
chromosomes.
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